z-logo
open-access-imgOpen Access
Benefits and Risks of Lung Cancer Screening
Author(s) -
Karl-Matthias Deppermann,
Hans Hoffmann,
Wilfried Eberhardt
Publication year - 2014
Publication title -
oncology research and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.553
H-Index - 48
eISSN - 2296-5262
pISSN - 2296-5270
DOI - 10.1159/000365234
Subject(s) - medicine , lung cancer , cancer , colorectal cancer , breast cancer , oncology , prostate cancer , stage (stratigraphy) , asymptomatic , paleontology , biology
12,715 (20) 657 (1.0) 81 197 (0.3) a Non-smokers, as defined in the respective studies. b Number of participants with suspicious, non-calcifying lesions. c Number of participants with confirmed lung cancer at baseline. d Percentage of participants with stage I lung cancer. e Number of participants with confirmed lung cancer at first repeat.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom